Compare Gilead Sciences, Inc. (GILD) vs Kingsoft Cloud Holdings Limited (KC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gilead Sciences, Inc. vs Kingsoft Cloud Holdings Limited — how do they compare? Gilead Sciences, Inc. trades at $149.49 (market cap $182.40B), while Kingsoft Cloud Holdings Limited trades at $9.31 (market cap $2.71B). The key difference: Gilead Sciences, Inc. is far larger — about 67.3× Kingsoft Cloud Holdings Limited's market cap, and Gilead Sciences, Inc. pays a 2.23% dividend while Kingsoft Cloud Holdings Limited pays none. Which is the better fit depends on your goals — on Pluang, investors hold Gilead Sciences, Inc. for 111 Days and Kingsoft Cloud Holdings Limited for 12 Days on average.
| GILD | KC | |
|---|---|---|
Market Cap | $182.40B | $2.71B |
Volume | 4,469,821 | 1,993,765 |
Sector | Health | Technology |
52-Week High | $155.80 | $18.21 |
52-Week Low | $116.74 | $8.58 |
Typical Hold Time | 111 Days | 12 Days |
Enterprise Value | $205.46B | $3.03B |
Dividend Yield | 2.23% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gilead Sciences (GILD) trades at $146.85, up 1.82% today, with a bullish technical signal from moving averages and recent earnings beats in Q4 2025 and Q1 2026. The company reported strong 2025 revenue of $29.44B and net income of $8.51B, though 2026 projections show a net loss. Key developments include a partnership with PAHO to expand HIV prevention drug access in Latin America, supporting long-term growth prospects amid mixed profitability metrics.
The outlook for GILD is cautiously optimistic, driven by analyst consensus favoring a buy rating (65.52%) and a price target of $151.57. Opportunities lie in HIV and oncology pipeline advancements, but risks include negative 2026 profit margins and high debt levels. Investors should weigh strong cash flow from operations against execution risks in a competitive biopharma landscape.
Kingsoft Cloud (KC) trades at $9.23, down 1.28% today, with a bearish technical signal from moving averages. The company shows improving fundamentals with Q2 2026 revenue growth of 30.8% year-over-year and three consecutive earnings beats. Despite negative net income margins, gross margins improved significantly in Q2, and AI cloud services are emerging as a key growth driver. Analyst sentiment remains positive with 70% buy ratings and a consensus price target suggesting 60.3% upside potential.
The outlook is cautiously optimistic as KC transitions toward profitability, driven by AI cloud adoption and strategic partnerships. Key risks include persistent losses, competitive pressures in Chinese cloud services, and macroeconomic uncertainties. The stock offers growth potential but requires monitoring of margin improvement and cash flow sustainability amid heavy investments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Gilead Sciences, Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
Read more on GILD →About Kingsoft Cloud Holdings Limited
Kingsoft Cloud is a leading independent cloud service provider in China. It offers a comprehensive suite of cloud products and solutions tailored for industries like gaming, video streaming, and financial services.
Read more on KC →
